Study protocol approved by ethical committee.
journal contribution
posted on 2022-07-13, 17:36 authored by Marieke B. J. Toffolo, Jamie R. Fehribach, Chris P. B. J. van Klaveren, Ilja Cornelisz, Annemieke van Straten, Jean-Louis van Gelder, Tara Donker(PDF)
History
Usage metrics
Keywords
waitlist control groupusers &# 8217trial nl9221 ).score &# 8805netherlands trial registrymain outcome measuregeneral dutch populationdata collection startedcommon specific phobiasinvestigate whether zerophobiahigh refusal ratesproviding exposure therapymake exposure therapyspider phobia usingincluding restricted availabilitygold standard treatmentaugmented reality selfexposure therapyspider phobiaaugmented realityhigh costszerophobia applicationxlink ">vivo usage intensitytwelve participantsseptember 25september 2021secondary measuresrandomly assignedoctober 11novel technologiesmonth followmay helphelp ethical approvale .,automated appadditional measures
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC